US Patent Issued to FRESENIUS MEDICAL CARE DEUTSCHLAND on June 24 for "Method for regulating the supply of substituate during extracorporeal blood treatment and extracorporeal blood treatment device comprising a unit for regulating the supply of substituate" (German Inventors)

ALEXANDRIA, Va., June 25 -- United States Patent no. 12,337,093, issued on June 24, was assigned to FRESENIUS MEDICAL CARE DEUTSCHLAND GMBH (Bad Homburg, Germany).

"Method for regulating the supply of substituate during extracorporeal blood treatment and extracorporeal blood treatment device comprising a unit for regulating the supply of substituate" was invented by Pascal Kopperschmidt (Dittelbrunn, Germany) and Alfred Gagel (Litzendorf, Germany).

According to the abstract* released by the U.S. Patent & Trademark Office: "A method that regulates supply of substituate in an extracorporeal blood treatment with an extracorporeal blood treatment apparatus comprising a dialyzer divided by a semipermeable membrane into a blood chamber and a di...